Open access · CC-BY
via OpenAlex
Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome
Archana Arjunan, Dhiraj Kumar Sah, Minna Woo, Juhyun Song
Cell & Bioscience · 2023 · ▲ 97 citations
Abstract
Neurodegenerative disorders are accompanied by neuronal degeneration and glial dysfunction, resulting in cognitive, psychomotor, and behavioral impairment. Multiple factors including genetic, environmental, metabolic, and oxidant overload contribute to disease progression. Recent evidences suggest that metabolic syndrome is linked to various neurodegenerative diseases. Metabolic syndrome (MetS) is known to be accompanied by symptoms such as hyperglycemia, abdominal obesity, hypertriglyceridemia, and hypertension. Despite advances in knowledge about the pathogenesis of neurodegenerative disorders, effective treatments to combat neurodegenerative disorders caused by MetS have not been developed to date. Insulin growth factor-1 (IGF-1) deficiency has been associated with MetS-related pathologies both in-vivo and in-vitro. IGF-1 is essential for embryonic and adult neurogenesis, neuronal plasticity, neurotropism, angiogenesis, metabolic function, and protein clearance in the brain. Here, we review the evidence for the potential therapeutic effects of IGF-1 in the neurodegeneration related to metabolic syndrome. We elucidate how IGF-1 may be involved in molecular signaling defects that occurs in MetS-related neurodegenerative disorders and highlight the importance of IGF-1 as a potential therapeutic target in MetS-related neurological diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13578-023-00966-z
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Arjunan, A., Sah, D.K., Woo, M., & Song, J. (2023). Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome. <em>Cell & Bioscience</em>. https://doi.org/10.1186/s13578-023-00966-z
Vancouver
Arjunan A, Sah DK, Woo M, Song J. Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome. Cell & Bioscience. 2023. doi:10.1186/s13578-023-00966-z.
BibTeX
@article{archana2023Identi,
title = {Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome},
author = {Archana Arjunan and Dhiraj Kumar Sah and Minna Woo and Juhyun Song},
journal = {Cell & Bioscience},
year = {2023},
doi = {10.1186/s13578-023-00966-z},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2013
Open access · CC-BY
A novel inhibitor of the insulin/IGF signaling pathway protects from age‐onset, neurodegeneration‐linked proteotoxicity
Journal of Neurodegenerative Diseases 2012
Open access · CC-BY
Neurodegenerative Diseases: Multifactorial Conformational Diseases and Their Therapeutic Interventions
Frontiers in Pharmacology 2025
Open access · CC-BY
Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review
Nature and Science of Sleep 2025
Open access · CC-BY
Circadian Rhythm Dysfunction in Neurodegenerative Diseases: A Bidirectional Perspective and Therapeutic Potential
International Journal of Biological Macromolecules 2020
Citation only
Potential roles of telomeres and telomerase in neurodegenerative diseases
Frontiers in Genetics 2015
Open access · CC-BY